Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BScinoPharm Taiwan, Ltd. 〉Small Molecule Drugs

Small Molecule Drugs

Small Molecule Drugs

Small Molecule Drugs

Request for Collaboration
Overview
ScinoPharm possesses a full range of chemistry capabilities and has extensive experience in synthesizing complex molecules. Depending on individual requirements, we develop new synthetic routes, or scale up and optimize processes based on the customer's technology. Our synthesis studies include structured Design of Experiment. (DoE) methods used to identify optimal conditions, factors that most influence the results, as well as interactions and synergies between factors. In addition, process validation studies are conducted using parallel synthesizers and multiple reactors to define stress limits of the proposed plant process. Appropriate computer software programs are used to assist in the design of the experiments and in the analysis of experimental results.
 
Application
Currently Available Products (Products with US DMF or EDMF available are indicated in blue)
Abiraterone acetate
Anastrozole
Apixaban

Apremilast
Atazanavir sulfate
Azacitidine
Benazepril hydrochloride
Bimatoprost
Bivalirudin
Bortezomib*
Capecitabine
Celecoxib
Cladribine
Dantrolene sodium
Decitabine
Desmopressin acetate
Docetaxel anhydrous
Docetaxel trihydrate
Entecavir*
Enzalutamide
Everolimus
Exemestane
Flumazenil
Fluticasone propionate
Fulvestrant

Gefitinib
Galantamine
Galantamine hydrobromide
Gemcitabine hydrochloride
Granisetron hydrochloride
Ibrutinib
Irinotecan hydrochloride
Lapatinib ditosylate
Letrozole
Octreotide acetate
Omeprazole
Ondansetron hydrochloride
Paclitaxel*
Regadenoson*
Riluzole*
Roflumilast
SN38
Tamsulosin hydrochloride
Topiramate
Topotecan hydrochloride
Travoprost
Zoledronic acid
* Products exclusive in certain areas
Products under Development
Brexpiprazole
Cangrelor tetrasodium
Leuprolide acetate
Linaclotide
Olaparib
Palbociclib
Pimavanserin tartrate
Sugammadex sodium
Tenofovir disoproxil fumarate
Ticagrelor
 
Patent Portfolio
Taiwan, a WTO member, has been continuously ranked one of the top players in the world in terms of receiving US patents. ScinoPharm, through its Singapore subsidiary, has filed a number of Patent Cooperation Treaty (PCT) patent applications and some of them have been granted for registrations. Our emphasis on intellectual property protection has enabled us to establish successful relationships with many major pharmaceutical companies.
We are committed to strict adherence to United States and international intellectual property standards to protect our own and our customers' intellectual property rights. All facilities are equipped with physical security equal to U.S. plants, including card-key/electronic monitoring, bound/numbered research notebooks, 24-hour on-site security, video monitoring throughout the plant site, and motion detectors along all perimeter fence lines. In addition to the facilities, we also periodically provide our employees with training programs of intellectual property protection and aim to ensure that all of our employees understand and comply with our intellectual property protection policy.
Our success will depend, in part, on our ability to obtain and enforce patents, protect trade secrets, obtain licenses to technology from our collaborators when necessary, and conduct our business without infringing the proprietary rights of others. We have a policy of seeking patent protection for any patentable proprietary technology. In short, we seek patent protection for the products and processes developed in the course of our research when we believe such protection is in our best interest.
We also provide CRO service to our customers.  In most cases, the ownership of proprietary technology developed by us in the course of work performed under the contract is vested in the customers, and we retain little or no ownership.
More Information
People who like this also like
  • HPAPI manufacturingHPAPI manufacturing
  • Noninvasive prenatal screening by next generation sequencing of maternal plasma DNANoninvasive prenatal screening by next generation sequencing of maternal plasma DNA
  • NGS-SMSEQ®NGS-SMSEQ®
  • Lesion Detecting Method and Lesion Detecting Apparatus for Breast Image in Rotating MannerLesion Detecting Method and Lesion Detecting Apparatus for Breast Image in Rotating Manner
  • PHDC-01PHDC-01
  • SB05SB05
  • Carrier screening for fragile X syndromeCarrier screening for fragile X syndrome
  • Burixafor (TG-3000)Burixafor (TG-3000)
  • Platform_Polymeric MicellePlatform_Polymeric Micelle
  • Lead optimizationLead optimization